Avita Medical (RCEL) Insider Trading & Ownership $4.56 +0.18 (+4.11%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$4.55 -0.01 (-0.22%) As of 09/12/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Avita Medical (NASDAQ:RCEL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.80%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$243.35KNumber OfInsiders Selling(Last 12 Months)0 Get RCEL Insider Trade Alerts Want to know when executives and insiders are buying or selling Avita Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RCEL Insider Buying and Selling by Quarter Avita Medical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/28/2025Robert McnamaraDirectorBuy10,000$4.50$45,000.00 8/26/2025David D O'tooleCFOBuy2,000$4.52$9,040.00 8/19/2025Robert McnamaraDirectorBuy10,000$5.00$50,000.00 8/12/2025David D O'tooleCFOBuy2,000$4.81$9,620.00 2/20/2025Robert McnamaraDirectorBuy10,000$10.09$100,900.00 2/19/2025David D O'tooleCFOBuy1,000$10.25$10,250.00 12/9/2024Suzanne CroweDirectorBuy486$13.15$6,390.90 12/5/2024David D O'tooleCFOBuy975$12.46$12,148.50 (Data available from 1/1/2013 forward) RCEL Insider Trading Activity - Frequently Asked Questions Who is on Avita Medical's Insider Roster? The list of insiders at Avita Medical includes David D O'toole, Donna Shiroma, James Corbett, Jeremy Curnock Cook, Michael S Perry, Robert Mcnamara, and Suzanne Crowe. Learn more on insiders at RCEL. What percentage of Avita Medical stock is owned by insiders? 2.80% of Avita Medical stock is owned by insiders. Learn more on RCEL's insider holdings. Which Avita Medical insiders have been buying company stock? The following insiders have purchased RCEL shares in the last 24 months: David D O'toole ($92,156.00), Robert Mcnamara ($195,900.00), and Suzanne Crowe ($6,390.90). How much insider buying is happening at Avita Medical? Insiders have purchased a total of 40,911 RCEL shares in the last 24 months for a total of $294,446.90 bought. Which Avita Medical insiders have been selling company stock? The following insiders have sold RCEL shares in the last 24 months: James Corbett ($19,204.05), and Jeremy Curnock Cook ($30,895.86). How much insider selling is happening at Avita Medical? Insiders have sold a total of 3,963 Avita Medical shares in the last 24 months for a total of $50,099.91 sold. Avita Medical Key ExecutivesMr. James M. Corbett (Age 66)CEO, President & Executive Director Compensation: $1.16MMr. David O'Toole (Age 65)Chief Financial Officer Compensation: $574.64kMs. Donna Shiroma (Age 61)General Counsel, Chief Compliance Officer & Secretary Compensation: $688.6kMr. David FencilSenior Vice President of Global OperationsDr. Katie Bush Ph.D.Senior Vice President of Scientific & Medical AffairsMs. Jessica EkebergInvestor Relations ExecutiveMs. Debbie GarnerSenior Vice President of Global Marketing & StrategyMr. Rob HallSenior Vice President of Human ResourcesMr. Terry BromleySenior Vice President of Global SalesDr. Niraj Doshi J.D.P.M.P., Ph.D., Senior Vice President of Product Development & Program Management More Insider Trading Tools from MarketBeat Related Companies Treace Medical Concepts Insider Selling CeriBell Insider Selling Semler Scientific Insider Selling Delcath Systems Insider Selling Butterfly Network Insider Selling RxSight Insider Selling Sanuwave Health Insider Selling NeuroPace Insider Selling ClearPoint Neuro Insider Selling Tactile Systems Technology Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in OutlookDueling Insider Moves: Heavy Buying Here, Big Selling There This page (NASDAQ:RCEL) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone thought he was insane…SpaceX just struck a $17 billion deal with EchoStar for radio frequencies, and tech analyst Jeff Brown says it...Brownstone Research | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avita Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avita Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.